Legend Biotech (LEGN) Share-based Compensation (2020 - 2026)
Legend Biotech (LEGN) reported Share-based Compensation of $17.4 million for Q2 2026, down 7.0% from $18.7 million a year earlier and down 9.8% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Legend Biotech's Share-based Compensation came in at $66.7 million, up 5.8% year-over-year; for FY2025, it came in at $64.6 million, down 6.2% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 68.5% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $68.9 million in FY2024 (+44.4%), $47.7 million in FY2023 (+38.9%), $34.34 million in FY2022 (+70.3%) and $20.16 million in FY2021 (+323.5%).
- Five-year quarterly Share-based Compensation spans a low of $5.2 million in Q4 2021 and a high of $21.74 million in Q2 2024.
- Year over year, Share-based Compensation gained in four of the last eight quarters, with growth averaging 3.1%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 573.6%); the low point was Q1 2025 (a decline of 15.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $19.3 million (Q1 2026), $14.94 million (Q4 2025) and $15.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Legend Biotech | 3.43 Bn | -308.34 Mn | 251.50 Mn | 17.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.40 Mn |
| Mar 31, 2026 | 19.30 Mn |
| Dec 31, 2025 | 14.94 Mn |
| Sep 30, 2025 | 15.06 Mn |
| Jun 30, 2025 | 18.70 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 13.35 Mn |
| Sep 30, 2024 | 15.11 Mn |
| Jun 30, 2024 | 21.74 Mn |
| Mar 31, 2024 | 18.70 Mn |
| Dec 31, 2023 | 12.61 Mn |
| Sep 30, 2023 | 12.38 Mn |
| Jun 30, 2023 | 15.65 Mn |
| Mar 31, 2023 | 7.07 Mn |
| Dec 31, 2022 | 8.97 Mn |
| Sep 30, 2022 | 10.24 Mn |
| Jun 30, 2022 | 9.45 Mn |
| Mar 31, 2022 | 5.67 Mn |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 6.93 Mn |
API Access
Legend Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();